CMPS COMPASS Pathways Plc - American Depository Shares
$13,94
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 5, 2026
Zakres 52 tyg.
$4–$15
87% of range
Ocena Analityków
BUY
24 analysts
Cena Docelowa
$24
+70% upside
P/E (TTM)
-4.5
ROE
-524.8%
Marża Zysku Netto
—
O COMPASS Pathways Plc - American Depository Shares Przegląd firmy z Wikipedii
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Czytaj więcej
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CMPS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$13.94
Kapitalizacja Rynkowa
$1.34B
P/E (TTM)
-4.5
EPS (TTM)
$-3.08
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-524.8%
D/E Dług/Kapitał
-0.6
Zakres 52 tyg.
$4 – $15
CMPS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-3.08
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2021-12-31
→
2024-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CMPS
Mediana porównawcza
P/E (TTM)
-4.5
66.9
P/B
-25.3
3.7
EV / EBITDA
-6.8
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CMPS
Mediana porównawcza
ROA
-135.8%
-23.9%
ROE
-524.8%
-27.7%
ROIC
836.7%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CMPS
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
-0.6
4.4
Current Ratio (Wskaźnik bieżący)
0.8
4.0
Quick Ratio (Wskaźnik Szybkości)
0.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CMPS
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CMPS
Mediana porównawcza
CMPS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
24 analityków
- Mocne kupno 8 33,3%
- Kup 14 58,3%
- Trzymaj 2 8,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
16 analityków · 2026-08-16
Mediana
$21.00
Teraz
$13.94
Niski
$13.00
Wysoki
$65.00
Średni cel
$21.00
+50,6%
Średnia cel
$23.75
+70,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.27%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-1.88 | $-0.41 | -1.5% |
| 31 marca 2026 | $0.71 | $-0.39 | 1.1% |
| 31 grudnia 2025 | $-1.00 | $-0.40 | -0.60% |
| 30 września 2025 | $-1.44 | $-0.40 | -1.0% |
| 30 czerwca 2025 | $-0.41 | $-0.44 | 0.03% |
| 31 marca 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 grudnia 2024 | $-0.63 | $-0.64 | 0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
Bilans 22
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
Rentowność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
Wycena (TTM) 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
Rentowność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-288M | $-155M | $-118M | $-92M | $-72M |
| Rozwodniony EPS | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | -0.6 | 0.2 | — | — | — |
| Wskaźnik bieżący | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| Wskaźnik Szybkości | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | $-119M | $-97M | $-106M | $-68M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 250 emitentów · $1.3B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 66 (+6 vs poprzedni kw.) | 30 (+7 vs poprzedni kw.) | 77 (+3 vs poprzedni kw.) | 53 (+26 vs poprzedni kw.) | -2.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Deep Track Capital, LP | $172 085 168 | 12 161 496 | 13,73% | Akcje |
| RTW INVESTMENTS, LP | $151 418 782 | 10 700 974 | 12,08% | Akcje |
| BIT Capital GmbH | $89 835 478 | 6 348 797 | 7,17% | Akcje |
| TANG CAPITAL MANAGEMENT LLC | $70 750 000 | 5 000 000 | 5,65% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $63 257 363 | 4 470 485 | 5,05% | Akcje |
| ARK Investment Management LLC | $48 845 310 | 3 451 965 | 3,90% | Akcje |
| Point72 Asset Management, L.P. | $37 085 424 | 2 620 878 | 2,96% | Akcje |
| Logos Global Management LP | $31 837 500 | 2 250 000 | 2,54% | Akcje |
| Eagle Health Investments LP | $29 155 042 | 2 060 427 | 2,33% | Akcje |
| DAFNA Capital Management LLC | $28 469 121 | 2 011 952 | 2,27% | Akcje |
| BANK OF AMERICA CORP /DE/ | $28 339 691 | 2 002 805 | 2,26% | Akcje |
| Caption Management, LLC | $27 544 390 | 1 946 600 | 2,20% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26 855 285 | 1 897 900 | 2,14% | Opcja kupna |
| NEXTBio Capital Management LP | $25 126 990 | 1 775 759 | 2,00% | Akcje |
| MARSHALL WACE, LLP | $20 935 350 | 1 479 530 | 1,67% | Akcje |
| Aisling Capital Management LP | $20 267 554 | 1 432 336 | 1,62% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $20 261 229 | 1 431 889 | 1,62% | Akcje |
| Candriam S.C.A. | $18 013 686 | 1 274 278 | 1,44% | Akcje |
| Woodline Partners LP | $15 366 957 | 1 086 004 | 1,23% | Akcje |
| Jefferies Financial Group Inc. | $14 070 661 | 994 393 | 1,12% | Akcje |
| Trexquant Investment LP | $12 171 236 | 860 158 | 0,97% | Akcje |
| Kalehua Capital Management LLC | $11 598 642 | 819 692 | 0,93% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $10 909 466 | 770 987 | 0,87% | Akcje |
| Caption Management, LLC | $10 699 041 | 756 116 | 0,85% | Akcje |
| Eversept Partners, LP | $9 520 474 | 672 825 | 0,76% | Akcje |
| Propel Bio Management, LLC | $8 109 167 | 573 086 | 0,65% | Akcje |
| Creek Drive Management Group LLC | $8 093 800 | 572 000 | 0,65% | Akcje |
| Occam Crest Management LP | $7 739 000 | 710 000 | 0,62% | Akcje |
| CITADEL ADVISORS LLC | $7 567 420 | 534 800 | 0,60% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 140 090 | 504 600 | 0,57% | Opcja sprzedaży |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7 122 855 | 503 382 | 0,57% | Akcje |
| JANE STREET GROUP, LLC | $7 075 821 | 500 058 | 0,56% | Akcje |
| Qube Research & Technologies Ltd | $7 070 415 | 499 676 | 0,56% | Akcje |
| Walleye Capital LLC | $6 893 385 | 487 165 | 0,55% | Akcje |
| Ensign Peak Advisors, Inc | $6 716 340 | 474 653 | 0,54% | Akcje |
| Blue Owl Capital Holdings LP | $6 367 500 | 450 000 | 0,51% | Akcje |
| AdvisorShares Investments LLC | $5 962 060 | 421 347 | 0,48% | Akcje |
| CITADEL ADVISORS LLC | $5 952 679 | 420 684 | 0,47% | Akcje |
| TWO SIGMA ADVISERS, LP | $5 909 850 | 856 500 | 0,47% | Akcje |
| GOLDMAN SACHS GROUP INC | $5 540 956 | 391 587 | 0,44% | Akcje |
| HighVista Strategies LLC | $5 251 349 | 371 120 | 0,42% | Akcje |
| Legal & General Group Plc | $4 700 154 | 332 206 | 0,38% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $4 573 407 | 323 209 | 0,36% | Akcje |
| Amova Asset Management Americas, Inc. | $4 517 334 | 319 472 | 0,36% | Akcje |
| Squadron Capital Management LLC | $4 315 750 | 305 000 | 0,34% | Opcja kupna |
| Affinity Asset Advisors, LLC | $4 261 739 | 301 183 | 0,34% | Akcje |
| SEVEN GRAND MANAGERS, LLC | $4 245 000 | 300 000 | 0,34% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4 245 000 | 300 000 | 0,34% | Akcje |
| Squadron Capital Management LLC | $4 245 000 | 300 000 | 0,34% | Akcje |
| AMERIPRISE FINANCIAL INC | $4 081 271 | 288 429 | 0,33% | Akcje |
| JANE STREET GROUP, LLC | $4 079 445 | 288 300 | 0,33% | Opcja kupna |
| STEMPOINT CAPITAL LP | $4 029 481 | 284 769 | 0,32% | Akcje |
| TORONTO DOMINION BANK | $3 930 233 | 277 755 | 0,31% | Akcje |
| ROYCE & ASSOCIATES LP | $3 778 885 | 267 059 | 0,30% | Akcje |
| PFM Health Sciences, LP | $3 503 384 | 247 589 | 0,28% | Akcje |
| D. E. Shaw & Co., Inc. | $3 408 367 | 240 874 | 0,27% | Akcje |
| Brown University | $3 030 930 | 214 200 | 0,24% | Akcje |
| MORGAN STANLEY | $2 973 693 | 210 155 | 0,24% | Akcje |
| Caption Management, LLC | $2 950 275 | 208 500 | 0,24% | Opcja sprzedaży |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2 913 938 | 205 932 | 0,23% | Akcje |
| CITADEL ADVISORS LLC | $2 695 575 | 190 500 | 0,22% | Opcja sprzedaży |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2 481 528 | 175 373 | 0,20% | Akcje |
| Engineers Gate Manager LP | $2 432 343 | 171 897 | 0,19% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $2 378 474 | 168 090 | 0,19% | Akcje |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2 122 500 | 150 000 | 0,17% | Akcje |
| Squarepoint Ops LLC | $1 962 195 | 138 671 | 0,16% | Akcje |
| Balyasny Asset Management L.P. | $1 959 492 | 138 480 | 0,16% | Akcje |
| ALPS ADVISORS INC | $1 930 937 | 136 462 | 0,15% | Akcje |
| Founders Fund VII Management, LLC | $1 924 272 | 278 880 | 0,15% | Akcje |
| K2 PRINCIPAL FUND, L.P. | $1 911 665 | 135 100 | 0,15% | Akcje |
| WELLS FARGO & COMPANY/MN | $1 897 246 | 134 081 | 0,15% | Akcje |
| CenterBook Partners LP | $1 777 155 | 125 594 | 0,14% | Akcje |
| Creek Drive Management Group LLC | $1 698 000 | 120 000 | 0,14% | Opcja kupna |
| BANK OF MONTREAL /CAN/ | $1 686 991 | 119 222 | 0,13% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $1 639 118 | 115 839 | 0,13% | Akcje |
| Palo Alto Investors LP | $1 635 966 | 115 616 | 0,13% | Akcje |
| Simplify Asset Management Inc. | $1 617 076 | 114 281 | 0,13% | Akcje |
| LPL Financial LLC | $1 550 387 | 109 568 | 0,12% | Akcje |
| GROUP ONE TRADING LLC | $1 390 917 | 98 298 | 0,11% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $1 341 448 | 94 802 | 0,11% | Akcje |
| CreativeOne Wealth, LLC | $1 336 312 | 94 439 | 0,11% | Akcje |
| STABLEFORD CAPITAL II LLC | $1 300 003 | 91 873 | 0,10% | Akcje |
| STATE STREET CORP | $1 150 098 | 81 279 | 0,09% | Akcje |
| Lion Point Capital, LP | $1 132 000 | 80 000 | 0,09% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 063 896 | 75 187 | 0,08% | Akcje |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1 016 635 | 71 847 | 0,08% | Akcje |
| DLD Asset Management, LP | $990 500 | 70 000 | 0,08% | Opcja sprzedaży |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941 852 | 66 562 | 0,08% | Akcje |
| Aquatic Capital Management LLC | $922 297 | 65 180 | 0,07% | Akcje |
| JANE STREET GROUP, LLC | $915 505 | 64 700 | 0,07% | Opcja sprzedaży |
| Dorsey Wright & Associates | $883 653 | 62 449 | 0,07% | Akcje |
| Campbell & CO Investment Adviser LLC | $874 696 | 61 816 | 0,07% | Akcje |
| STIFEL FINANCIAL CORP | $855 639 | 60 469 | 0,07% | Akcje |
| Intellectus Partners, LLC | $841 925 | 59 500 | 0,07% | Akcje |
| DCF Advisers, LLC | $767 638 | 54 250 | 0,06% | Akcje |
| CIBC WORLD MARKET INC. | $737 357 | 52 110 | 0,06% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $731 420 | 51 727 | 0,06% | Akcje |
| FLAX POND CAPITAL, LLC | $728 951 | 51 516 | 0,06% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $708 943 | 50 102 | 0,06% | Akcje |
| PEAK6 LLC | $707 500 | 50 000 | 0,06% | Opcja kupna |
Insiderzy spółki 9 insiderów · 0 dyrektorzy generalni · 0 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 3 sierpnia 2026 F | 361 028 | 0 | 0 | $0 |
| Robert Mcquade | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| David Y Norton | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Gino Santini | — | 27 maja 2026 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 27 maja 2026 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 17 lutego 2026 | 4,96% | Aneks | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 6 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,43% | 3 316 076 NS | 30 kwietnia 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,99% | 40 950 NS | 30 kwietnia 2026 | N-PORT |
| BIB · ProShares Trust | 0,06% | 3 487 NS | 31 maja 2026 | N-PORT |
| APIE · Trust for Professional Managers | 0,03% | 21 455 NS | 31 maja 2026 | N-PORT |
| IBB · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 lipca 2026 | Dziennie |